Woodward Drug Patent Portfolio
Woodward owns 2 orange book drugs protected by 9 US patents Given below is the list of Woodward's drug patents along with their expiration dates.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US7732488 | Pharmaceutical composition comprising low concentrations of environmental pollutants | 30 Jan, 2025 | Active |
US7358366 | Thiazolidinedione derivative and its use as antidiabetic | 19 Oct, 2020 | Expired |
US7358366 | Thiazolidinedione derivative and its use as antidiabetic | 19 Apr, 2020 | Expired |
US6288095 | Compounds | 11 Aug, 2017 | Expired |
US5656667 | Fatty acid composition | 10 Apr, 2017 | Expired |
US6288095 | Compounds | 11 Feb, 2017 | Expired |
US5741803 | Substituted thiazolidinedionle derivatives | 21 Oct, 2015 | Expired |
US5741803 | Substituted thiazolidinedionle derivatives | 21 Apr, 2015 | Expired |
US5502077 | Fatty acid composition | 26 Mar, 2013 | Expired |
Latest Legal Activities on Woodward's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Woodward.
Activity | Date | Patent Number |
---|---|---|
Payment of Maintenance Fee, 12th Year, Large Entity | 23 Nov, 2021 | US7732488 |
Payment of Maintenance Fee, 8th Year, Large Entity | 04 Dec, 2017 | US7732488 |
Expire Patent
Critical
| 14 May, 2012 | US7358366 |
Recordation of Patent Grant Mailed
Critical
| 08 Jun, 2010 | US7732488 |
Patent Issue Date Used in PTA Calculation
Critical
| 08 Jun, 2010 | US7732488 |
Issue Notification Mailed
Critical
| 19 May, 2010 | US7732488 |
Dispatch to FDC | 27 Apr, 2010 | US7732488 |
Application Is Considered Ready for Issue
Critical
| 26 Apr, 2010 | US7732488 |
Issue Fee Payment Received
Critical
| 22 Apr, 2010 | US7732488 |
Issue Fee Payment Verified
Critical
| 22 Apr, 2010 | US7732488 |
Printer Rush- No mailing | 13 Apr, 2010 | US7732488 |
Pubs Case Remand to TC
Critical
| 01 Mar, 2010 | US7732488 |
Mail Notice of Allowance
Critical
| 26 Jan, 2010 | US7732488 |
Case Docketed to Examiner in GAU
Critical
| 20 Jan, 2010 | US7732488 |
Notice of Allowance Data Verification Completed
Critical
| 20 Jan, 2010 | US7732488 |
Woodward's Family Patents
Woodward Drug List
Given below is the complete list of Woodward's drugs and the patents protecting them.
1. Avandia
Avandia is protected by 6 patents, out of which all have expired. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US7358366
(Pediatric)
| Thiazolidinedione derivative and its use as antidiabetic |
19 Oct, 2020
(3 years ago)
| Expired |
US7358366 | Thiazolidinedione derivative and its use as antidiabetic |
19 Apr, 2020
(4 years ago)
| Expired |
US6288095
(Pediatric)
| Compounds |
11 Aug, 2017
(7 years ago)
| Expired |
US6288095 | Compounds |
11 Feb, 2017
(7 years ago)
| Expired |
US5741803
(Pediatric)
| Substituted thiazolidinedionle derivatives |
21 Oct, 2015
(8 years ago)
| Expired |
US5741803 | Substituted thiazolidinedionle derivatives |
21 Apr, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Avandia's drug page
2. Lovaza
Lovaza is protected by 3 patents, out of which 2 have expired. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US7732488 | Pharmaceutical composition comprising low concentrations of environmental pollutants |
30 Jan, 2025
(3 months from now)
| Active |
US5656667 | Fatty acid composition |
10 Apr, 2017
(7 years ago)
| Expired |
US5502077 | Fatty acid composition |
26 Mar, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Lovaza's drug page